Skip to main content

Table 1 Child demographics

From: Sankofa pediatric HIV disclosure intervention did not worsen depression scores in children living with HIV and their caregivers in Ghana

  Disclosure Status  
No (N = 35) Yes (N = 122) Total (N = 157) p Value
Gender
 Female 019 (54.29%) 060 (49.18%) 079 (50.32%)  
 Male 016 (45.71%) 062 (50.82%) 078 (49.68%) 0.59 a
Child Age
 Mean (95% CL) 8.88 (8.25–9.51) 10.31 (9.86–10.75) 9.99 (9.61–10.37) < 0.001c, ***
 Median (IQR) 9 (7–10) 10 (8–12) 10 (8–12)  
 N (N Missing) 33 (2) 118 (4) 151 (6)  
School
 Yes 030 (85.71%) 116 (95.08%) 146 (92.99%)  
 No 002 (5.71%) 001 (0.82%) 003 (1.91%)  
 Patient refused to answer 000 (0.00%) 001 (0.82%) 001 (0.64%)  
 Missing 003 (8.57%) 004 (3.28%) 007 (4.46%) 0.20 b
HIV Transmission Mode
 MTC 025 (71.43%) 100 (81.97%) 125 (79.62%)  
 Other 001 (2.86%) 003 (2.46%) 004 (2.55%)  
 Missing 009 (25.71%) 019 (15.57%) 028 (17.83%) 1.00 b
Duration of HIV (days)
 Mean (95% CL) 1503.60 (1006.07–2001.13) 1749.07 (1545.42–1952.71) 1702.58 (1514.83–1890.32) 0.31 c
 Median (IQR) 1264 (406–2513) 1928 (747–2588) 1898 (745–2579)  
 N (N Missing) 25 (10) 107 (15) 132 (25)  
Duration of ART treatment (days)
 Mean (95% CL) 804.92 (381.21–1228.64) 1355.88 (1162.56–1549.19) 1246.53 (1068.69–1424.37) 0.014 c, *
 Median (IQR) 350 (32–1208) 1389 (406–2145) 1281 (147–2107)  
 N (N Missing) 26 (9) 105 (17) 131 (26)  
WHO Staging at time of Diagnosis
 Stage 1 003 (8.57%) 016 (13.11%) 019 (12.10%)  
 Stage 2 006 (17.14%) 044 (36.07%) 050 (31.85%)  
 Stage 3 014 (40.00%) 030 (24.59%) 044 (28.03%)  
 Stage 4 002 (5.71%) 013 (10.66%) 015 (9.55%)  
 Missing 010 (28.57%) 019 (15.57%) 029 (18.47%) 0.10 a
HIV+ caregiver
 Yes 017 (48.57%) 079 (64.75%) 096 (61.15%)  
 No or Unsure 017 (48.57%) 040 (32.79%) 057 (36.31%)  
 Missing 001 (2.86%) 003 (2.46%) 004 (2.55%) 0.08 a
Does anyone help you take your medicine?
 Yes 024 (68.57%) 101 (82.79%) 125 (79.62%)  
 No 006 (17.14%) 012 (9.84%) 018 (11.46%)  
 Missing 005 (14.29%) 009 (7.38%) 014 (8.92%) 0.21 a
Who helps you with your medicine most of the time?
 Biological parent (Mother/Father) 017 (48.57%) 075 (61.48%) 092 (58.60%)  
 Family (Grandparent/Aunt/Uncle) 006 (17.14%) 013 (10.66%) 019 (12.10%)  
 Other family member 001 (2.86%) 010 (8.20%) 011 (7.01%)  
 Other 000 (0.00%) 002 (1.64%) 002 (1.27%)  
 Unknown 000 (0.00%) 001 (0.82%) 001 (0.64%)  
 Missing 011 (31.43%) 021 (17.21%) 032 (20.38%) 0.55 b
Days since disclosure
 Mean (95% CL) NA (NA – NA) 1540.62 (1467.34–1613.90) 1540.62 (1467.34–1613.90)  
 Median (IQR) NA (NA – NA) 1573 (1215–1834) 1573 (1215–1834)  
 N (N Missing) 0 (35) 121 (1) 121 (36)  
Days since enrollment
 Mean (95% CL) 1603.26 (1461.08–1745.43) 1914.43 (1851.38–1977.48) 1845.06 (1783.96–1906.15) < 0.001c, ***
 Median (IQR) 1519 (1238–1921) 1941 (1624–2243) 1893 (1519–2215)  
  1. Legend: * p < 0.05, *** p < 0.001
  2. a Chi-square test, b Fisher’s Exact test, c T test
  3. Abbreviations: ART antiretroviral therapy; CL confidence level; IQR interquartile range; MTC mother-to-child